Co-infections: potentially lethal and unexplored in COVID-19
- PMID: 32835323
- PMCID: PMC7195315
- DOI: 10.1016/S2666-5247(20)30009-4
Co-infections: potentially lethal and unexplored in COVID-19
Comment in
-
Low rate of bacterial co-infection in patients with COVID-19.Lancet Microbe. 2020 Jun;1(2):e62. doi: 10.1016/S2666-5247(20)30036-7. Epub 2020 Jun 8. Lancet Microbe. 2020. PMID: 32835331 Free PMC article. No abstract available.
-
The role of oral bacteria in COVID-19.Lancet Microbe. 2020 Jul;1(3):e105. doi: 10.1016/S2666-5247(20)30057-4. Epub 2020 Jul 3. Lancet Microbe. 2020. PMID: 32835339 Free PMC article. No abstract available.
-
Mucosal-Associated Invariant T Cells as a Possible Target to Suppress Secondary Infections at COVID-19.Front Immunol. 2020 Aug 4;11:1896. doi: 10.3389/fimmu.2020.01896. eCollection 2020. Front Immunol. 2020. PMID: 32849648 Free PMC article. No abstract available.
Similar articles
-
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.Clin Infect Dis. 2021 Mar 1;72(5):e65-e75. doi: 10.1093/cid/ciaa1728. Clin Infect Dis. 2021. PMID: 33196783 Free PMC article.
-
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27. Clin Microbiol Infect. 2020. PMID: 32603803 Free PMC article.
-
Respiratory co-and superinfections in COVID-19.Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):69-71. doi: 10.37201/req/s01.20.2021. Epub 2021 Sep 30. Rev Esp Quimioter. 2021. PMID: 34598432 Free PMC article. Review.
-
Atypical bacterial co-infections among patients with COVID-19: A study from India.J Med Virol. 2022 Jan;94(1):303-309. doi: 10.1002/jmv.27324. Epub 2021 Sep 15. J Med Virol. 2022. PMID: 34491594 Free PMC article.
-
Impact of Coinfection With SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-Analysis.Front Public Health. 2021 Dec 10;9:773130. doi: 10.3389/fpubh.2021.773130. eCollection 2021. Front Public Health. 2021. PMID: 34957025 Free PMC article. Review.
Cited by
-
Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU.Ann Intensive Care. 2020 Sep 7;10(1):119. doi: 10.1186/s13613-020-00736-x. Ann Intensive Care. 2020. PMID: 32894364 Free PMC article.
-
The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis.Front Immunol. 2020 Jul 10;11:1712. doi: 10.3389/fimmu.2020.01712. eCollection 2020. Front Immunol. 2020. PMID: 32754164 Free PMC article. Review.
-
Evolution of the human pathogenic lifestyle in fungi.Nat Microbiol. 2022 May;7(5):607-619. doi: 10.1038/s41564-022-01112-0. Epub 2022 May 4. Nat Microbiol. 2022. PMID: 35508719 Free PMC article. Review.
-
Evaluation of the Diagnostic Performance of a SARS-CoV-2 and Influenza A/B Combo Rapid Antigen Test in Respiratory Samples.Diagnostics (Basel). 2023 Mar 3;13(5):972. doi: 10.3390/diagnostics13050972. Diagnostics (Basel). 2023. PMID: 36900116 Free PMC article.
-
The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome.Front Med (Lausanne). 2021 Jun 4;8:671714. doi: 10.3389/fmed.2021.671714. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34150807 Free PMC article. Review.
References
-
- Charalampous T, Kay GL, Richardson H. Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection. Nat Biotechnol. 2019;37:783–792. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical